Toggle navigation
News
OK
NewsOK
News
Weather
Opinion
Business
Sports
Life
Photos
Videos
Brandinsight
Shopping
Classifieds
Homes
Jobs
Cars
Legals
Shop
Account
Settings
Subscribe
Contact Us
Support
Privacy Policy
Terms of Use
About our ads
Advertise with us
The Oklahoman
Market Watch
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Gw Pharma ADR
(NQ:
GWPH
)
135.73
USD
-2.10 (-1.52%)
Official Closing Price
Updated: 7:37 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Gw Pharma ADR
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer
June 27, 2019
James Noble will transition to become a Non-Executive Director
From
GlobeNewswire News Releases
Continued Legalization Efforts Aid the Cannabis Market's Global Expansion
June 25, 2019
FinancialBuzz.com News Commentary
From
PR Newswire
Acquisitions, Licenses, Research Key in Consistent Cannabis Market Growth
June 20, 2019
From
CannabisNewsWire
Acquisitions, Licenses, Research Key in Consistent Cannabis Market Growth
June 20, 2019
CannabisNewsWire Editorial Coverage
From
PR Newswire
CannabisNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Advancing the Effective Delivery of Cannabinoids
June 13, 2019
From
CannabisNewsWire
Dramatically Improved Delivery Systems Promise More Effective Cannabis Treatments
June 11, 2019
From
CannabisNewsWire
Dramatically Improved Delivery Systems Promise More Effective Cannabis Treatments
June 11, 2019
CannabisNewsWire Editorial Coverage
From
PR Newswire
GW Pharmaceuticals to Present at the 40th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11th, 2019
June 04, 2019
GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of...
From
GlobeNewswire News Releases
CannabisNewsAudio – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Groundbreaking Delivery Technology Could Revolutionize the CBD Industry
May 31, 2019
From
CannabisNewsWire
Disruptive CBD Delivery Technology Could Revolutionize World of Cannabis Consumer Products, Edibles
May 29, 2019
From
CannabisNewsWire
Disruptive CBD Delivery Technology Could Revolutionize World of Cannabis Consumer Products, Edibles
May 29, 2019
CannabisNewsWire Editorial Coverage
From
PR Newswire
Public Figures Take a Prominent Stance in the Emerging CBD & Cannabis Space
May 28, 2019
FinancialBuzz.com News Commentary
From
PR Newswire
CannabisNewsAudio – VPR Brands, LP (VPRB) Increasing Customer Base with Clever Marketing Tactics
May 10, 2019
From
CannabisNewsWire
Analysts Earmark Numerous Strong Cannabis Market Drivers
May 10, 2019
FinancialBuzz.com News Commentary
From
PR Newswire
GW Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019
May 09, 2019
GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of...
From
GlobeNewswire News Releases
Surging Vape Market Propels Smart Brands Growth
May 08, 2019
From
CannabisNewsWire
Surging Vape Market Propels Smart Brands Growth
May 08, 2019
CannabisNewsWire Editorial Coverage
From
PR Newswire
GW Pharmaceuticals Reports Positive Phase 3 Pivotal Trial Results for EPIDIOLEX® (cannabidiol) Oral Solution in Patients with Seizures Associated With Tuberous Sclerosis Complex
May 06, 2019
GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of...
From
GlobeNewswire News Releases
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2019
May 06, 2019
GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development and commercialization of cannabinoid prescription medicines, announces financial...
From
GlobeNewswire News Releases
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol) oral solution, CV at the 2019 American Academy of Neurology Annual Meeting
May 02, 2019
Meeting activities include presentations of Phase 3 data, cannabinoid education for clinicians, and a virtual reality experience
From
GlobeNewswire News Releases
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending March 31, 2019 and Host Conference Call on May 6, 2019
April 23, 2019
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid...
From
GlobeNewswire News Releases
These are the 7 Biggest Marijuana Companies in the Legal Pot Industry
April 15, 2019
Tags
biggest marijuana companies
Business & Industrial
English
From
iCrowdNewswire
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Appointment of Darren Cline as U.S. Chief Commercial Officer
April 11, 2019
GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of cannabinoid prescription medicines, today announced the appointment of...
From
GlobeNewswire News Releases
CannabisNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Expands Reach as the CBD Industry Continues to Evolve
April 05, 2019
From
CannabisNewsWire
CBD Industry Set to Explode as New Products, Consumers Enter Market
April 03, 2019
From
CannabisNewsWire
CBD Industry set to Explode as New Products, Consumers Enter Market
April 03, 2019
CannabisNewsWire Editorial Coverage
From
PR Newswire
Research Report Identifies Plug Power, Milacron, Genesis Healthcare, Jounce Therapeutics, GW Pharmaceuticals, and Earthstone Energy with Renewed Outlook — Fundamental Analysis, Calculating Forward Mov
April 03, 2019
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Plug Power, Inc....
From
GlobeNewswire News Releases
GW Pharmaceuticals plc Announces the Sale of Priority Review Voucher for $105M
March 18, 2019
GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of cannabinoid prescription medicines, today announced that GW Research...
From
GlobeNewswire News Releases
Three of the Influential Health and Wellness Cannabis Companies
March 14, 2019
From
ACCESSWIRE
First Cannabinoid-Based Rapid Seizure Cessation Formulation Patent Granted to Colorado Startup
March 04, 2019
From
Press Release and Top News From 24-7 Press Release Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.